. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Midodrine for Treatment of Psoriasis

Reference #:

2001-155

Inventors/Contributors

Paola Sandroni, M.D., Ph.D., Mark R. Pittelkow, M.D., Phillip A. Low, M.D.

Description

Mayo Clinic researchers have identified a potential therapeutic role for midodrine HCL (ProAmatine) in the treatment of psoriasis. We propose that midodrine (or related alpha-agonists) have clinical potential in the therapy of psoriasis. Mayo has also identified a potential new formulation.

Patent Status

Pending

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410